NEW YORK (GenomeWeb) – Wafergen Biosystems today priced a public offering of its securities that is expected to bring in $15 million in gross proceeds.

As part of the offering, Wafergen intends to issue 3.9 million shares of common stock, shares of preferred stock convertible into 11.1 million shares of common stock, and warrants to purchase 15 million shares of common stock.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.